Market Overview

Innovations in Biopharmaceutical Treatments, 2018 Report -


The "Innovations
in Biopharmaceutical Treatments"
report has been added to's

This Drug Discovery TOE depicts trends across biopharmaceuticals for
psoriasis, hepatocellular carcinoma, Crohn's disease, migraine, HIV, and
hepatitis B infection, among others. Clinical trial analysis of
Etanercept biosimilar is also presented.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and
analyzes about the latest developments in drug discovery and
therapeutics, thereby providing an opportunity to acquire strategic
insights into crucial developments in this industry domain.

Technologies profiled include those used for biomarker and target
discovery such as high throughput screening, signal transduction, micro
array, RNAi, metabolomics, toxicogenomics, biosensors and
nanotechnology. In addition to these, a fair focus shall be dedicated to
the latest trends in therapeutic approaches across a diversity of
diseases including infectious, genetic, metabolic, neurological,
cardiac, and autoimmune disorders.

Key Topics Covered:

1. Advancements in Drug Discovery and Development

FDA-approved Drug to Provide Affordable Psoriasis Treatment Option

Ramucirumab Proves Promising Against Hepatocellular Carcinoma and
Bladder Cancer

Monoclonal Antibody Targeting Specific Cell Marker in Crohn's Disease

Calcitonin Gene-Related Peptide (CGRP) as a Drug Target for Migraine

Breakthrough Therapy for Multi-drug Resistant HIV Infection

Enhancing Biologics Manufacturing Capabilities

Accelerating Biosimilar Commercialization

Groundbreaking Treatment for X-linked Hypophosphatemia

Novel Immunotherapies for Hepatitis B and HIV

2. Drug Development Analysis and Key Contacts

Clinical Trial Analysis of Etanercept Biosimilar

Industry Contacts

For more information about this report visit

View Comments and Join the Discussion!